Profit

Hotel giant Marriott International (NASDAQ:MAR) has recently increased its annual adjusted profit forecast following a mixed performance in the first quarter. Despite weakening trends in North America, Marriott is relying on the surge in international travel demand to drive its full-year profit. The company anticipates a significant boost in revenue per available room (RevPAR) from
0 Comments
Australia’s major banks are anticipated to report weaker first-half profits as operating costs remain high and competition for mortgage and deposit sales intensifies. This has led to a reduction in margins, putting a strain on overall profitability. Although historically, rising interest rates have been beneficial for the Big Four banks, the current scenario has forced
0 Comments
Following the news of CEO Elon Musk’s decision to cut jobs in Tesla’s Supercharger team, the company’s shares plummeted nearly 6% on Tuesday, closing at $183.28. This drop marked a 26% decrease for the year, signaling investor concerns about the company’s future direction and financial stability. According to reports, Musk informed managers at Tesla about
0 Comments
Amazon recently reported its first-quarter earnings, surpassing expectations with both its earnings per share and revenue figures. The company’s revenue of $143.3 billion exceeded the forecasted $142.5 billion, while its earnings per share of 98 cents outperformed the expected 83 cents. The stock market reacted positively to the news, with Amazon’s stock price rising during
0 Comments
In recent years, the landscape of movie distribution has undergone significant changes, especially with the rise of eventized movies such as concert films. With the onset of the Covid-19 pandemic, studios began to embrace the theatrical day-and-date model as cinemas closed. However, the realization that theatrical releases bring in more profits and downstream revenues became
0 Comments
The recent ruling by U.S. District Judge Zahid Quraishi in Trenton, New Jersey, to uphold the law requiring drug manufacturers like Bristol Myers Squibb and Johnson & Johnson to negotiate prices of their blood clot prevention drugs with the U.S government’s Medicare program has sparked controversy in the pharmaceutical industry. Despite the drug companies’ arguments
0 Comments
In the midst of earnings season, investors are looking closely at top analysts’ picks for long-term prospects. Netflix (NFLX) takes the spotlight this week with its better-than-expected results for the first quarter of 2024. Despite the disappointment stemming from the company’s decision to halt reporting quarterly subscriber numbers, BMO Capital analyst Brian Pitz remains bullish
0 Comments
China’s industrial profits have taken a hit in March, with slower gains for the quarter compared to the initial two months of the year. Official data from the National Bureau of Statistics (NBS) revealed that cumulative profits of China’s industrial firms only rose by 4.3% to 1.5 trillion yuan ($207.0 billion) in the first quarter
0 Comments